
Global & Australia Dialysis Equipment Market to 2031
Description
The dialysis equipment market in Australia is influenced by a combination of demographic changes and a significant prevalence of chronic diseases, which together drive sustained demand for renal replacement therapy. The country’s population is aging steadily, with individuals aged 65 and older making up 17.6% of the population in 2024, a proportion that has been increasing over recent decades, according to data from the Australian Bureau of Statistics (ABS) and Knoema. This aging trend contributes to a higher incidence of chronic health conditions, particularly chronic kidney disease (CKD).
While the ABS National Health Survey in December 2023 reported a 1.0% prevalence of diagnosed kidney disease, more detailed data from 2022–2024 reveals that 14.2% of adults show signs of CKD, with the figure rising significantly to 44.7% among those aged 75 and above, indicating a notable rate of underdiagnosis, as reported by Ausmed in April 2025, based on ABS data. The main contributors to CKD progression to end-stage renal disease (ESRD) requiring dialysis are the increasing rates of diabetes and hypertension. According to the Australian Institute of Health and Welfare (AIHW), 5.1% of Australians were diagnosed with diabetes in 2021, while the ABS National Health Measures Survey (March 2025) indicated that 6.6% of adults had diabetes, based on blood tests. Hypertension, a significant risk factor for CKD, is even more widespread, further compounding the public health challenge.
This epidemiological landscape is driving the growing number of individuals requiring dialysis. Data from the AIHW, referencing ANZDATA 2023 figures, revealed that nearly 29,000 Australians were receiving kidney replacement therapy in 2022, with 53% of these patients undergoing dialysis. This number has more than doubled since 2003. A February 2025 report from DonateLife indicated that approximately 14,000 Australians are currently on dialysis. Hemodialysis remains the predominant treatment, with 83% of dialysis patients receiving it in 2022, primarily at satellite centers, reflecting the established infrastructure and continued demand for these vital treatments.
While the ABS National Health Survey in December 2023 reported a 1.0% prevalence of diagnosed kidney disease, more detailed data from 2022–2024 reveals that 14.2% of adults show signs of CKD, with the figure rising significantly to 44.7% among those aged 75 and above, indicating a notable rate of underdiagnosis, as reported by Ausmed in April 2025, based on ABS data. The main contributors to CKD progression to end-stage renal disease (ESRD) requiring dialysis are the increasing rates of diabetes and hypertension. According to the Australian Institute of Health and Welfare (AIHW), 5.1% of Australians were diagnosed with diabetes in 2021, while the ABS National Health Measures Survey (March 2025) indicated that 6.6% of adults had diabetes, based on blood tests. Hypertension, a significant risk factor for CKD, is even more widespread, further compounding the public health challenge.
This epidemiological landscape is driving the growing number of individuals requiring dialysis. Data from the AIHW, referencing ANZDATA 2023 figures, revealed that nearly 29,000 Australians were receiving kidney replacement therapy in 2022, with 53% of these patients undergoing dialysis. This number has more than doubled since 2003. A February 2025 report from DonateLife indicated that approximately 14,000 Australians are currently on dialysis. Hemodialysis remains the predominant treatment, with 83% of dialysis patients receiving it in 2022, primarily at satellite centers, reflecting the established infrastructure and continued demand for these vital treatments.
Table of Contents
110 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Australia Dialysis Equipment Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Dialysis Equipment Market Key Market Dynamics
- 5.1 Dialysis Equipment Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Australia Dialysis Equipment Market – Analysis
- 6.1 Australia Dialysis Equipment Market Revenue (US$ Million).2021–2031
- 6.2 Australia Dialysis Equipment Market Revenue and Forecast Analysis
- 7. Australia Dialysis Equipment Market Analysis – by Product
- 7.1 Australia Dialysis Equipment Market – Revenue and Forecast.2021–2031 (US$ Million) – by Product
- 8. Australia Dialysis Equipment Market Analysis – by Application
- 8.1 Australia Dialysis Equipment Market – Revenue and Forecast.2021–2031 (US$ Million) – by Application
- 9. Australia Dialysis Equipment Market Analysis – by End User
- 9.1 Australia Dialysis Equipment Market – Revenue and Forecast.2021–2031 (US$ Million) – by End User
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Fresenius Medical Care AG & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Baxter International Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Nipro Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Medtronic Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Nikkiso Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 DaVita Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Teleflex Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Asahi Kasei Medical Co., Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Terumo Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Australia Dialysis Equipment Market Segmentation
- Table 2. List of Vendors
- Table 3. Australia Dialysis Equipment Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Australia Dialysis Equipment Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Australia Dialysis Equipment Market – Revenue, 2021–2024 (US$ Million) – by Product
- Table 6. Australia Dialysis Equipment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Product
- Table 7. Australia Dialysis Equipment Market – Revenue, 2021–2024 (US$ Million) – by Application
- Table 8. Australia Dialysis Equipment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
- Table 9. Australia Dialysis Equipment Market – Revenue, 2021–2024 (US$ Million) – by End User
- Table 10. Australia Dialysis Equipment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Australia Dialysis Equipment Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.